Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,739 | 5,069 | 0 | 0 | 0 |
| Other current assets | 13 | 77 | 0 | 0 | 0 |
| TOTAL | $7,890 | $5,229 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,890 | $5,229 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 149 | 190 | 0 | 0 | 0 |
| Accrued Expenses | N/A | 11 | 0 | 0 | 0 |
| Other current liabilities | 94 | 16 | 0 | 0 | 0 |
| TOTAL | $242 | $217 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $242 | $217 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,366 | 1,354 | 1,118 | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 0 | 0 |
| Retained earnings | -32,081 | -30,354 | 0 | 0 | 0 |
| TOTAL | $7,648 | $5,012 | $0 | $0 | $0 |
| Total Liabilities And Equity | $7,890 | $5,229 | $0 | $0 | $0 |